HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Detection of anti-HAV IgM and anti-HEV IgM in patients with sporadic acute hepatitis in Beijing between 1995-2000].

AbstractOBJECTIVE:
To investigate the age ranges, liver function lesion and outcomes of sporadic acute hepatitis A and E in Beijing.
METHODS:
Enzyme immunoassay(EIA) was used for detection of anti-HAV and anti-HEV immunoglobulin M(IgM). Samples were collected from the patients with sporadic acute viral hepatitis in Beijing between 1995-2000.
RESULTS:
The total rate of positive for anti-HAV and anti-HEV was 55.2% (112) in 203 patients with acute hepatitis, 22.2% (45) and 33% (67) were positive separately for anti-HAV and anti-HEV in 112 patients. The duration of anti-HEV IgM was 45-60 days and that of anti-HAV IgM was at least 2-3 months. The patients with acute hepatitis A and hepatitis E all experienced jaundice, a rising of liver enzyme, but not developed to chronic hepatitis or to death.
CONCLUSION:
Acute hepatitis A as well as acute hepatitis E takes an important place in sporadic enterically transmitted hepatitis in Beijing.
AuthorsJ Lu, H Zhao, Q Mong
JournalZhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology (Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi) Vol. 15 Issue 2 Pg. 157-9 (Jun 2001) ISSN: 1003-9279 [Print] China
PMID11436647 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hepatitis Antibodies
  • Immunoglobulin M
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Child
  • China (epidemiology)
  • Hepatitis A (epidemiology, immunology)
  • Hepatitis A virus (immunology)
  • Hepatitis Antibodies (blood)
  • Hepatitis E (epidemiology, immunology)
  • Hepatitis E virus (immunology)
  • Humans
  • Immunoglobulin M (blood)
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: